UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease

Journal of vascular surgery, 2014-09, Vol.60 (3), p.804-804

2014

Volltextzugriff (PDF)

43 US Emergency Department Prescription of Oral Anticoagulants After Atrial Fibrillation Diagnosis

Annals of emergency medicine, 2016-10, Vol.68 (4), p.S19-S19

2016

Volltextzugriff (PDF)

ABNORMAL FIBRIN CLOT STRUCTURE IN ATRIAL FIBRILLATION

Canadian journal of cardiology, 2014-10, Vol.30 (10), p.S321-S321

2014

Volltextzugriff (PDF)

Omega‐3 polyunsaturated acids and cardiovascular disease: notable ethnic differences or unfulfilled promise?

Journal of thrombosis and haemostasis, 2010-10, Vol.8 (10), p.2095-2104

2010

Volltextzugriff (PDF)

Validation Of The Apixaban Cost-Effectiveness Model In Patients With Non-Valvular Atrial Fibrillation

Value in health, 2014-05, Vol.17 (3), p.A113-A113

2014

Volltextzugriff (PDF)

C0487: NT-proBNP Provided Complementary Prognostic Information to an Established Clinical Risk Score (CHA2DS2-VASc) for the Prediction of Stroke/Systemic Embolism

Thrombosis research, 2014-05, Vol.133, p.S18-S18

2014

Volltextzugriff (PDF)

PCV144 Stroke Prevention in Patients with Atrial Fibrillation: Inappropriate Anticoagulation and Poor INR Control

Value in health, 2011, Vol.14 (7), p.A390-A390

2011

Volltextzugriff (PDF)

Erratum to “Circulating adiponectin reflects severity of coronary atherosclerosis but not cardiac function abnormalities” [Atheroscler. Suppl. 9 (May (1)) (2008) 78]

Atherosclerosis, 2011-10, Vol.218 (2), p.553-553

2011

Volltextzugriff (PDF)

WS01.06 Evaluating trends in cardiovascular events in people with cystic fibrosis before and after elexacaftor/tezacaftor/ivacaftor initiation – a retrospective review in federated electronic healthcare record

Journal of cystic fibrosis, 2024-06, Vol.23, p.S2-S3

2024

Volltextzugriff (PDF)

WS10.03 Increasing cardiovascular risk in adults with cystic fibrosis related diabetes receiving CFTR modulator therapy (elexacaftor/tezacaftor/ivacaftor)

Journal of cystic fibrosis, 2023-06, Vol.22, p.S20-S21

2023

Volltextzugriff (PDF)

Symptom status, clinical subtypes and prognosis in Middle East patients with atrial fibrillation: a report from the Gulf-SAFE registry

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

82 The Impact of Stroke Prophylaxis on Clinical Outcomes After US Emergency Department Diagnosis and Discharge for Atrial Fibrillation

Annals of emergency medicine, 2018-10, Vol.72 (4), p.S36-S36

2018

Volltextzugriff (PDF)

106 Stroke Prophylaxis and 30-Day Clinical Outcomes After US Emergency Department Diagnosis and Discharge for Atrial Fibrillation

Annals of emergency medicine, 2017-10, Vol.70 (4), p.S43-S43

2017

Volltextzugriff (PDF)

State of play and future direction with NOACs: An expert consensus

Vascular pharmacology, 2018-07, Vol.106, p.9-21

2018

Volltextzugriff (PDF)

Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction

International journal of cardiology, 2017-09, Vol.243, p.9-14

2017

Volltextzugriff (PDF)

Impaired endothelial function may underlies increased arterial stiffness in South Asian stroke survivors compared to European Caucasians counterparts in the United Kingdom

Artery research, 2008-08, Vol.2 (3), p.120-120

2008

Volltextzugriff (PDF)

PCV67 - Validation Of The Apixaban Cost-Effectiveness Model In Patients With Non-Valvular Atrial Fibrillation

Value in health, 2014-05, Vol.17 (3), p.A113-A113

2014

Volltextzugriff (PDF)

P2.57 Impaired Endothelial Function May Underlies Increased Arterial Stiffness in South Asian Stroke Survivors Compared to European Caucasians Counterparts in the United Kingdom

Artery research, 2008, Vol.2 (3), p.120-120

2008

Volltextzugriff (PDF)

Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension

Journal of human hypertension, 2011-05, Vol.25 (5), p.304-310

2011

Volltextzugriff (PDF)

DIASTOLIC DYSFUNCTION IN HYPERTENSIVES AS ASSESSED BY TISSUE DOPPLER; RELATION TO MATRIX METALLOPROTEINASES

Echocardiography (Mount Kisco, N.Y.), 2004-07, Vol.21 (5), p.485-485

2004

Volltextzugriff (PDF)

512 ETHNIC DIFFERENCES IN CIRCULATING MARKERS OF ANGIOGENESIS AND THEIR ASSOCIATION WITH CARDIOVASCULAR RISK FACTORS AND PERIPHERAL ARTERIAL DISEASE

Atherosclerosis. Supplements, 2011-06, Vol.12 (1), p.109-109

2011

Volltextzugriff (PDF)

626 APOA5 -1131 T>C POLYMORPHISM IS A DETERMINANT OF TRIGLYCERIDE LEVELS IN THE SOUTH ASIAN POPULATION

Atherosclerosis. Supplements, 2011-06, Vol.12 (1), p.132-132

2011

Volltextzugriff (PDF)

P65 ARTERIAL STIFFNESS IN PAROXYSMAL ATRIAL FIBRILLATION: RELATIONSHIP WITH MICRO- AND MACROVASCULAR ENDOTHELIAL DYSFUNCTION AND CARDIOVASCULAR DISEASE

Atherosclerosis. Supplements, 2010-06, Vol.11 (2), p.30-30

2010

Volltextzugriff (PDF)

CIRCULATING ADIPONECTIN REFLECTS SEVERITY OF CORONARY ATHEROSCLEROSIS, BUT NOT - CARDIAC FUNCTION ABNORMALITIES

Atherosclerosis. Supplements, 2008-05, Vol.9 (1), p.78-78

2008

Volltextzugriff (PDF)

WITHDRAWN: Erratum to “Circulating adiponectin reflects severity of coronary atherosclerosis but not cardiac function abnormalities” [Atheroscler. Suppl. 9 (1) (2008) 78]

Atherosclerosis. Supplements, 2008-12

2008

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease

43 US Emergency Department Prescription of Oral Anticoagulants After Atrial Fibrillation Diagnosis

ABNORMAL FIBRIN CLOT STRUCTURE IN ATRIAL FIBRILLATION

Omega‐3 polyunsaturated acids and cardiovascular disease: notable ethnic differences or unfulfilled promise?

Validation Of The Apixaban Cost-Effectiveness Model In Patients With Non-Valvular Atrial Fibrillation

C0487: NT-proBNP Provided Complementary Prognostic Information to an Established Clinical Risk Score (CHA2DS2-VASc) for the Prediction of Stroke/Systemic Embolism

PCV144 Stroke Prevention in Patients with Atrial Fibrillation: Inappropriate Anticoagulation and Poor INR Control

Erratum to “Circulating adiponectin reflects severity of coronary atherosclerosis but not cardiac function abnormalities” [Atheroscler. Suppl. 9 (May (1)) (2008) 78]

WS01.06 Evaluating trends in cardiovascular events in people with cystic fibrosis before and after elexacaftor/tezacaftor/ivacaftor initiation – a retrospective review in federated electronic healthcare record

WS10.03 Increasing cardiovascular risk in adults with cystic fibrosis related diabetes receiving CFTR modulator therapy (elexacaftor/tezacaftor/ivacaftor)

Symptom status, clinical subtypes and prognosis in Middle East patients with atrial fibrillation: a report from the Gulf-SAFE registry

82 The Impact of Stroke Prophylaxis on Clinical Outcomes After US Emergency Department Diagnosis and Discharge for Atrial Fibrillation

106 Stroke Prophylaxis and 30-Day Clinical Outcomes After US Emergency Department Diagnosis and Discharge for Atrial Fibrillation

State of play and future direction with NOACs: An expert consensus

Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction

Impaired endothelial function may underlies increased arterial stiffness in South Asian stroke survivors compared to European Caucasians counterparts in the United Kingdom

PCV67 - Validation Of The Apixaban Cost-Effectiveness Model In Patients With Non-Valvular Atrial Fibrillation

P2.57 Impaired Endothelial Function May Underlies Increased Arterial Stiffness in South Asian Stroke Survivors Compared to European Caucasians Counterparts in the United Kingdom

Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension

DIASTOLIC DYSFUNCTION IN HYPERTENSIVES AS ASSESSED BY TISSUE DOPPLER; RELATION TO MATRIX METALLOPROTEINASES

512 ETHNIC DIFFERENCES IN CIRCULATING MARKERS OF ANGIOGENESIS AND THEIR ASSOCIATION WITH CARDIOVASCULAR RISK FACTORS AND PERIPHERAL ARTERIAL DISEASE

626 APOA5 -1131 T>C POLYMORPHISM IS A DETERMINANT OF TRIGLYCERIDE LEVELS IN THE SOUTH ASIAN POPULATION

P65 ARTERIAL STIFFNESS IN PAROXYSMAL ATRIAL FIBRILLATION: RELATIONSHIP WITH MICRO- AND MACROVASCULAR ENDOTHELIAL DYSFUNCTION AND CARDIOVASCULAR DISEASE

CIRCULATING ADIPONECTIN REFLECTS SEVERITY OF CORONARY ATHEROSCLEROSIS, BUT NOT - CARDIAC FUNCTION ABNORMALITIES

WITHDRAWN: Erratum to “Circulating adiponectin reflects severity of coronary atherosclerosis but not cardiac function abnormalities” [Atheroscler. Suppl. 9 (1) (2008) 78]

Suchergebnisse filtern